Press release
Oncology Biosimilars Market Estimated to Flourish by 2025
Besides this, leading pharmaceutical companies are entering into strategic alliances with leading generic manufacturers to develop biosimilars. A case in point is Biocon. The company entered into a strategic collaboration with Mylan to develop a strong portfolio of biosimilars, including recombinant proteins and monoclonal antibodies.
Cancer is considered the second-leading cause of death worldwide, says an analyst at TMR. Driven by the need to develop affordable treatment options for cancer, and various other factors, the global oncology biosimilars market is projected to expand at a phenomenal CAGR of 27.5% for the forecast period between 2017 and 2025. At this pace, the market that stood at US$2,100 mn in 2016 will become US$17,478.2 mn by the end of 2025.
The G-CSF drug class segment led the market in 2016 in terms of revenue, and is anticipated to remain dominant over the forecast period. The growth of this segment is attributed to strong pipeline portfolio of key players in the biosimilars market. Hospital pharmacy led amongst key distribution channels in 2016 vis-à-vis revenue and the trend is expected to continue until the end of the forecast period in 2025.
Asia Pacific is a significant market for oncology biosimilars. A robust pipeline of biosimilars of key players in India, and practices of strategic alliances for the development and commercialization of biosimilars is expected to fuel the growth of Asia Pacific oncology biosimilars market.
Read Report Overview @https://www.transparencymarketresearch.com/oncology-biosimilars-market.html
Majorly fuelling the growth of oncology biosimilars market is the need to develop affordable therapies for the treatment of cancer. This is because cancer is presently the costliest health affair in terms of diagnosis as well as treatment. Pharmaceutical companies across the world are focused on developing biosimilars and generic medicines to combat cancer at all stages and for early detection of all types of malignancies.
Request Sample Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14696
Oncology biosimilars are officially approved versions of oncology biologics that are cost-effective with similar efficacy and potency as original reference biologic. They differ from biologics in terms of manufacturing process and complexity, and can also be manufactured after the patent expiration of original reference biologic. This, along with a robust pipeline of biosimilars is expected to generate promising opportunities for the market in the next few years.
Request Oncology Biosimilars Market Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14696
In Europe and Asia, Non-Hodgkin and neutropenia are the major disorders where oncology biosimilars are used. Apart from this, various biosimilars are in the pipeline for the treatment of breast cancer and lung cancer.
On the flip side, need for a complex infrastructure for the production of biosimilars and a lengthy process for biosimilars to receive approval from regulatory bodies are proving to be a roadblock to the market’s growth.
Buy Full Oncology Biosimilars Market Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=14696<ype=S
About TMR
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Contact
Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
TMR Blog: http://www.theglobalhealthnews.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oncology Biosimilars Market Estimated to Flourish by 2025 here
News-ID: 814607 • Views: …
More Releases from Transparency Market Research
Epithelioma Treatment Market Outlook 2035: Rising Skin Cancer Burden, Breakthrou …
The global epithelioma treatment market has entered a decisive growth phase, supported by rising cancer prevalence and rapid therapeutic innovation. In 2024, the market was valued at US$ 5.1 Bn, reflecting the growing demand for advanced diagnostic and therapeutic solutions targeting epithelial-origin tumors. Over the forecast period from 2025 to 2035, the industry is projected to expand at a robust compound annual growth rate (CAGR) of 8.8%, reaching a valuation…
Tablet Hardness Testers Market to Reach USD 427.9 Mn by 2036, Driven by Rising P …
The Tablet Hardness Testers Market is a critical part of the pharmaceutical quality-control ecosystem. Tablet hardness testers are used to measure the mechanical strength of tablets to ensure they can withstand handling, packaging, transportation, and storage without breaking, while still dissolving correctly once ingested. As regulatory oversight becomes stricter and pharmaceutical production expands globally, the demand for accurate and reliable hardness testing equipment continues to rise.
The global Tablet Hardness Testers…
Dental Tourism Market to Reach US$ 87.7 Billion by 2035, Driven by Rising Demand …
The global dental tourism market was valued at US$ 11.7 billion in 2024 and is projected to reach an impressive US$ 87.7 billion by 2035, expanding at a robust CAGR of 20.1% from 2025 to 2035. The market's rapid expansion is primarily driven by the rising demand for cost-effective yet premium dental treatments, growing cross-border healthcare accessibility, and continuous advancements in dental technologies that enhance treatment quality and patient outcomes.
Access…
Physical Therapy Software Market Outlook 2035: Global Market to Expand from US$ …
The global physical therapy software market is witnessing strong and sustained growth as healthcare systems increasingly adopt digital tools to improve clinical efficiency, patient engagement, and treatment outcomes. Valued at US$ 1.3 billion in 2024, the market is projected to reach US$ 3.4 billion by 2035, expanding at a compound annual growth rate (CAGR) of 9.2% from 2025 to 2035. This expansion reflects the growing demand for technology-driven rehabilitation services,…
More Releases for TMR
Cancer Diagnostics Market Reviews 2031 | TMR Study
According to a Transparency Market Research (TMR) research report, the global cancer diagnostics Market is likely to expand at a CAGR of 7.4% during the forecast period, 2022 to 2031. This suggests that the market is expected to reach US$ 335.7 Bn by the end of 2031.
The study on the cancer diagnostics Market adopts rigorous and systematic research approaches to understand the growth dynamic of the market. The authors have…
LED Work Light Market 2029 | TMR Research
LED Work Light Market: Overview
The LED work light market may gain good momentum in terms of growth across the forecast period of 2019-2029 due to the growing demand from residential segments and the overwhelming benefits it provides. These high-intensity light fixtures are mainly used by technicians to assist them in their work temporarily. The use of LED work lights is increasing among many end-users due to benefits like longevity, durability,…
Dissolved Gas Analyzer Market 2025 | TMR Research
Global Dissolved Gas Analyzer Market: Overview
The high electrical and thermal stress leads to decomposition of mineral oils used inside a power transformer. This in turn leads to generation of hydrogen (H2), carbon di-oxide (CO2), carbon mono-oxide (CO), methane (CH4), ethylene (C2H4), and acetylene (C2H2) among others. The formation of these gases depends upon the faults in the transformer.
To evaluate the nature of the gases and their potential threats, dissolved gas…
Tumblers Market 2028 | TMR Research
The tumblers market is expected to set growth straight with rising demand for new attractive designs for liquors including alcoholic, and non-alcoholic in emerging region of Asia pacific. The rising disposable income, increasing access to quality products, and new product launches customised to suit the taste of the region promise major growth for the tumblers market in near future.
Download Brochure of This Market Report at - https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6200
Among regions, North America,…
Hyperloop Train Market 2025 | TMR Research
Global Hyperloop Train Market: Snapshot
The global market for hyperloop train is likely to exhibit high-speed expansion in the next few years. The demand for cheap and quick modes of transport that incur low base-costs and are built on easier-to-construct infrastructure, are immune to natural calamities such as earthquakes are the key factors expected to work in favor of the global hyperloop train market.
Request Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=2000
The…
Crowdsourced Security Market 2018 - 2028 | TMR Research
Crowdsourced Security Market: Overview
The global crowdsourced security market is expected develop at a healthy pace in the coming years of the forecast period of 2018 to 2028. The mobile phone application segment of the crowdsourced security market is expected to develop at a rapid pace in these coming years. The rate of adoption of these mobile application is growing at a great pace and is thus helping the market to…
